tiprankstipranks
Ab&B Bio-Tech CO., LTD. JS Class H (HK:2627)
:2627
Hong Kong Market
Want to see HK:2627 full AI Analyst Report?

Ab&B Bio-Tech CO., LTD. JS Class H (2627) Ratios

1 Followers

Ab&B Bio-Tech CO., LTD. JS Class H Ratios

HK:2627's free cash flow for Q2 2025 was ¥0.91. For the 2025 fiscal year, HK:2627's free cash flow was decreased by ¥ and operating cash flow was ¥-0.41. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23
Liquidity Ratios
Current Ratio
0.44 0.55
Quick Ratio
0.32 0.48
Cash Ratio
0.13 0.15
Solvency Ratio
-0.07 -0.14
Operating Cash Flow Ratio
-0.03 -0.22
Short-Term Operating Cash Flow Coverage
-0.07 -0.57
Net Current Asset Value
¥ -1.14B¥ -970.72M
Leverage Ratios
Debt-to-Assets Ratio
0.64 0.53
Debt-to-Equity Ratio
27.71 5.86
Debt-to-Capital Ratio
0.97 0.85
Long-Term Debt-to-Capital Ratio
0.94 0.76
Financial Leverage Ratio
43.31 11.00
Debt Service Coverage Ratio
-0.20 -0.50
Interest Coverage Ratio
-10.30 -12.93
Debt to Market Cap
0.11 0.07
Interest Debt Per Share
2.62 2.23
Net Debt to EBITDA
-9.61 -4.00
Profitability Margins
Gross Profit Margin
85.46%58.34%
EBIT Margin
-156.37%-92.83%
EBITDA Margin
-132.14%-70.03%
Operating Profit Margin
-149.16%-88.24%
Pretax Profit Margin
-170.86%-99.65%
Net Profit Margin
-170.86%-99.65%
Continuous Operations Profit Margin
-170.86%-99.65%
Net Income Per EBT
100.00%100.00%
EBT Per EBIT
114.54%112.93%
Return on Assets (ROA)
-7.61%-16.04%
Return on Equity (ROE)
-142.93%-176.49%
Return on Capital Employed (ROCE)
-16.20%-32.53%
Return on Invested Capital (ROIC)
-9.46%-21.64%
Return on Tangible Assets
-7.74%-16.30%
Earnings Yield
-1.21%-2.10%
Efficiency Ratios
Receivables Turnover
0.44 0.85
Payables Turnover
0.02 0.24
Inventory Turnover
0.09 1.87
Fixed Asset Turnover
0.07 0.25
Asset Turnover
0.04 0.16
Working Capital Turnover Ratio
-0.14 -0.71
Cash Conversion Cycle
-12.00K -865.87
Days of Sales Outstanding
833.05 429.37
Days of Inventory Outstanding
4.17K 195.09
Days of Payables Outstanding
17.00K 1.49K
Operating Cycle
5.00K 624.46
Cash Flow Ratios
Operating Cash Flow Per Share
-0.08 -0.51
Free Cash Flow Per Share
-0.20 -1.02
CapEx Per Share
0.12 0.51
Free Cash Flow to Operating Cash Flow
2.47 2.00
Dividend Paid and CapEx Coverage Ratio
-0.68 -1.00
Capital Expenditure Coverage Ratio
-0.68 -1.00
Operating Cash Flow Coverage Ratio
-0.03 -0.23
Operating Cash Flow to Sales Ratio
-0.45 -0.77
Free Cash Flow Yield
-0.86%-3.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-82.72 -47.53
Price-to-Sales (P/S) Ratio
129.40 47.37
Price-to-Book (P/B) Ratio
272.62 83.89
Price-to-Free Cash Flow (P/FCF) Ratio
-116.68 -30.77
Price-to-Operating Cash Flow Ratio
-315.30 -61.64
Price-to-Earnings Growth (PEG) Ratio
-0.83 1.22
Price-to-Fair Value
272.62 83.89
Enterprise Value Multiple
-107.54 -71.64
Enterprise Value
10.11B 13.02B
EV to EBITDA
-107.53 -71.64
EV to Sales
142.08 50.17
EV to Free Cash Flow
-128.11 -32.59
EV to Operating Cash Flow
-316.96 -65.28
Tangible Book Value Per Share
0.02 0.31
Shareholders’ Equity Per Share
0.09 0.37
Tax and Other Ratios
Effective Tax Rate
0.00 0.00
Revenue Per Share
0.18 0.66
Net Income Per Share
-0.31 -0.66
Tax Burden
1.00 1.00
Interest Burden
1.09 1.07
Research & Development to Revenue
1.39 0.79
SG&A to Revenue
1.03 0.47
Stock-Based Compensation to Revenue
0.04 0.16
Income Quality
0.37 0.77
Currency in CNY